. 
EXPERIMENTAL PROCEDURES

General experimental procedures
All chemicals and media components were purchased from commercial sources and used without further purification. All 1 H, 13 C, DEPT 135, and 2D NMR ( 1 H-1 H COSY, HSQC, HMBC, ROESY) spectra were collected with a Bruker Avance III Ultrashield 700 at 700 MHz for 1 H and 175 MHz for 13 C nuclei. Preparative HPLC was carried out on an Agilent 1260 Infinity LC equipped with an Agilent Eclipse XDB-C18 column (250 mm × 21.2 mm, 7 μm). LC-MS was conducted using an Agilent 1260 Infinity LC coupled to a 6230 TOF (HRESI) equipped with an Agilent Poroshell 120 EC-C18 column (50 mm × 4.6 mm, 2.7 μm). Optical rotations were measured using an AUTOPOL IV automatic polarimeter (Rudolph Research Analytical). UV spectra were obtained with a NanoDrop 2000C spectrophotometer (Thermo Scientific). IR spectra were attained using a Spectrum One FT-IR spectrophotometer (PerkinElmer).
Bacterial strains, plasmids, and culture conditions
Strains, plasmids, and polymerase chain reaction (PCR) primers used in this study are summarized in Tables S1-S3, respectively. E. coli DH5α was used for general cloning and plasmid/cosmid preparations. PCR primers were obtained from Sigma-Aldrich. Q5 DNA polymerase, restriction endonucleases, and T4 DNA ligase were obtained from NEB and all reactions were performed following the manufacturer's protocols. Commercial kits for gel extraction and plasmid preparation were purchased from Omega Bio-Tek. DNA sequencing was performed by Eton Bioscience. The REDIRECT Technology kit for λRED-mediated PCRtargeting mutagenesis was graciously provided by the John Innes Center (Norwich, UK).
1 E. coli ET12567/pUZ8002 2 was used as the E. coli host for intergeneric conjugation with Streptomyces spp. spores. S. platensis SB12029 and pBS12039 were previously reported. 3 E. coli strains containing plasmids or cosmids were grown in lysogeny broth (LB) with appropriate antibiotic selection. Recombinant Streptomyces strains were cultured in liquid tryptic soy broth (TSB) or on solid ISP4 medium with appropriate antibiotic selection. E. coliStreptomyces conjugations and fermentations of Streptomyces spp. were performed as previously described. [3] [4] [5] Briefly, intergeneric conjugations were performed on solid ISP4 freshly supplemented with 10 mM MgCl 2 . For pre-fermentation seed cultures, Streptomyces spp. spores were inoculated into seed medium and incubated at 28 °C and 250 rpm for 2 d. PTM fermentation medium was inoculated with 4% (v/v) seed culture and 3% (w/v) Amberlite XAD-16 resin (Sigma-Aldrich) and cultured at 28 °C and 250 rpm for 7 d.
Inactivation of ptmB1, ptmB2, ptmT2, and ptmC Gene replacement of ptmB1 was performed in E. coli BW25113/pIJ790 carrying pBS12039, a cosmid containing a partial ptm gene cluster, but not ptmR1, 3 by λRED-mediated PCR-targeting as described above (Table S3 ). The ptmB1 gene was replaced with the aac(3)IV + oriT cassette from pIJ773 1 resulting in pBS12043. pBS12043 was introduced into S. platensis SB12029 by intergeneric conjugation as described above yielding SB12032. Double-crossover mutants were selected for by apramycin resistance and kanamycin sensitivity. The ptmB1 mutation in S.
S3
platensis SB12032 was confirmed by PCR analysis using primers 739B1ID_F and 739B1ID_R ( Figure S2 ).
Gene replacement of ptmB2 was performed in E. coli BW25113/pIJ790 carrying pBS12039 by λRED-mediated PCR-targeting as described above. The ptmB2 gene was replaced with the aac(3)IV + oriT cassette from pIJ773 1 resulting in pBS12044. pBS12044 was introduced into S. platensis SB12029 by intergeneric conjugation and double-crossover mutants were selected as described above yielding SB12033. The ptmB2 mutation in S. platensis SB12033 was confirmed by PCR analysis using primers 739B2ID_F and 739B2ID_R ( Figure S3 ).
Gene replacement of ptmT2 was performed in E. coli BW25113/pIJ790 carrying pBS12039 by λRED-mediated PCR-targeting as described above. The ptmT2 gene was replaced with the aac(3)IV + oriT cassette from pIJ773 1 resulting in pBS12045. pBS12045 was introduced into S. platensis SB12029 by intergeneric conjugation and double-crossover mutants were selected as described above yielding SB12034. The ptmT2 mutation in S. platensis SB12034 was confirmed by PCR analysis using primers 739T2ID_F and 739T2ID_R ( Figure S4 ).
Gene replacement of ptmC was performed in E. coli BW25113/pIJ790 carrying pBS12039 by λRED-mediated PCR-targeting as described above. The ptmC gene was replaced with the aac(3)IV + oriT cassette from pIJ773 1 resulting in pBS12046. pBS12046 was introduced into S. platensis SB12029 by intergeneric conjugation and double-crossover mutants were selected as described above yielding SB12035. The ptmC mutation in S. platensis SB12035 was confirmed by PCR analysis using primers 739T2ID_F and 739T2ID_R ( Figure S5 ).
Fermentations with aryl variants
Fermentation of S. platensis recombinant strains was performed using previously reported protocols. 3, 5, 6 Spores of S. platensis were inoculated into TSB and incubated at 28 °C and 250 rpm for 2 d. PTM fermentation medium supplemented with 3% (w/v) Amberlite XAD-16 resin (Sigma-Aldrich) was inoculated with 4% (v/v) of the resultant seed culture. For the recombinant strains with no aryl variant added, after shaking at 250 rpm for 7 d at 28 °C, the fermented broth was harvested and centrifuged to pellet the resin. For the fermentations with aryl variants, each aryl variant (10 mg) was dissolved in 200 µL of autoclaved DMSO. Since several heteroaryl variants had poor solubility in DMSO, H 2 O was used and supplemented with 1M HCl until the solid fully dissolved. After 1.5 d, the culture was fed with 5 mg of the aryl variant (in DMSO) and incubated for another 1 d, before adding another 5 mg of the aryl variant (in DMSO). After shaking for another 4.5 d at 28 °C, the fermented broth was harvested and centrifuged to pellet the resin.
Extraction, LC-MS analysis, and isolation
Extraction of resin from small-scale fermentations followed previously reported protocols. 5, 6 After fermentation of the recombinant Streptomyces strains, the resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. The supernatant (aqueous layer) was also directly used for LC-MS analysis. Liquid chromatography S4 for LC-MS analysis was performed using an 18 min solvent gradient (0.4 mL min -1 ) from 5% -100% CH 3 CN containing 0.1% formic acid in H 2 O containing 0.1% formic acid.
Each isolated PTM analogue generated by mutasynthesis was named platensimycin with "F" designating that these analogues were constructed by feeding experiments.
Platensimycin F1 (3m). The cultures of two small flasks, each containing 50 mL of fermentation culture supplemented with 3 (10 mg each), were combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -80% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 3m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 5% -100% CH 3 
Platensimycin F2 (6m).
The cultures of two small flasks, each containing 50 mL of fermentation culture supplemented with 6 (10 mg each), were combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -80% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 6m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 20% -80% CH 3 
Platensimycin F3 (7m).
One large flask containing 500 mL of fermentation culture was supplemented with 7 (100 mg). The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 10% -80% CH 3 Platensimycin F4 (8m-b). One large flask containing 500 mL of fermentation culture was supplemented with 8 (100 mg). The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -50% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 8m-b were pooled and further chromatographed over a preparative reversephase HPLC using an elution system of 10% -60% CH 3 
Platensimycin F5 (13m).
The cultures of two large flasks, each containing 500 mL of fermentation culture supplemented with 13 (100 mg each) was combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 10% -70% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 13m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 20% -85% CH 3 
Platensimycin F6 (17m).
The cultures of two large flasks, each containing 500 mL of fermentation culture supplemented with 17 (100 mg each) was combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -60% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 17m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 20% -80% CH 3 
Platensimycin F7 (19m).
The cultures of four large flasks, each containing 500 mL of fermentation culture supplemented with 19 (100 mg each) was combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -60% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 19m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 5% -100% CH 3 
Platensimycin F8 (24m).
The cultures of two small flasks, each containing 50 mL of fermentation culture supplemented with 24 (10 mg each), were combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -60% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 24m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 20% -80% CH 3 F9 (27m-a) and F10 (27m-b) . The cultures of two large flasks, each containing 500 mL of fermentation culture supplemented with 27 (100 mg each) was combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 20% -80% CH 3 CN in H 2 O containing 0.1% formic acid to afford two subfractions of Fr01 and Fr02. Fraction Fr01 was further chromatographed over a preparative reverse-phase HPLC using an elution system of 30% -100% CH 3 Platensimycin F11 (32m). The cultures of two small flasks, each containing 50 mL of fermentation culture supplemented with 32 (10 mg each), were combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -60% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 32m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 20% -80% CH 3 
Platensimycin F12 (34m).
The cultures of two small flasks, each containing 50 mL of fermentation culture supplemented with 34 (10 mg each), were combined. The resin was harvested by centrifugation, washed three times with H 2 O, and extracted three times with methanol. Methanol was removed by rotary evaporation and the resulting oil was resuspended in methanol. The precipitate was removed by centrifugation and the supernatant was subjected to a preparative reverse-phase HPLC using an elution system of 5% -85% CH 3 CN in H 2 O containing 0.1% formic acid. Fractions containing 34m were pooled and further chromatographed over a preparative reverse-phase HPLC using an elution system of 10% -100% CH 3 
